Antivascular Endothelial Growth Factor Antibody for Treatment of Glioblastoma Multiforme

Despite aggressive investigation, glioblastoma multiforme (GBM) remains one of the deadliest cancers, with low progression-free survival and high one-year mortality. Current first-line therapy includes surgery with adjuvant radiation therapy and cytotoxic chemotherapy, but virtually all tumors recur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hanson, Joseph A, Hsu, Frank P K, Jacob, Arun T, Bota, Daniela A, Alexandru, Daniela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Permanente Journal 2013
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854812/
https://ncbi.nlm.nih.gov/pubmed/24361023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/13-081
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak